These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Increased expression of CD54, CD18, MHC class II molecules, and proliferating cell nuclear antigen in acute puromycin aminonucleoside nephrosis. Fernandez L, Romero M, Rincón J, Mosquera J. Nephron Exp Nephrol; 2003 Nov; 94(2):e55-65. PubMed ID: 12845231 [Abstract] [Full Text] [Related]
33. Sequence of development of hypercholesterolemia and hypoproteinemia in aminonucleoside nephrosis. DUBACH UC, RECANT L, HATCH E, KOCH M. Proc Soc Exp Biol Med; 1960 Dec; 105():592-3. PubMed ID: 13724549 [No Abstract] [Full Text] [Related]
35. Biochemical studies of the isolated rat glomerulus and the effects of puromycin aminonucleoside administration. Bhuyan UN, Welbourn CR, Evans DJ, Peters TJ. Br J Exp Pathol; 1980 Feb; 61(1):69-75. PubMed ID: 6246912 [Abstract] [Full Text] [Related]
36. Changes in glomerular heparan sulfate in puromycin aminonucleoside nephrosis. Groggel GC, Hovingh P, Border WA, Linker A. Am J Pathol; 1987 Sep; 128(3):521-7. PubMed ID: 2443012 [Abstract] [Full Text] [Related]